NVCR Q1 2021 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q1 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$135M+32.3% YoY

Gross Profit

$108M80.4% margin

Operating Income

-$88,000-0.1% margin

Net Income

-$4M-3.1% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-6.4%

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$14M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$695M

Stockholders' Equity

$372M

Cash & Equivalents

$315M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$135M	$102M	+32.3%
Gross Profit	$108M	$77M	+40.1%
Operating Income	-$88,000	-$3M	+97.4%
Net Income	-$4M	$4M	-204.5%

Geographic Segments

UNITED STATES

$86M64%

GERMANY

$26M20%

EMEA, Exculding Germany

$9M6%

JAPAN

$8M6%

CHINA

$6M4%